Procedure | Pediatric tubes (n = 100) | Adult tubes (n = 100) | Absolute difference (95% CI) | Risk ratio (95% CI) |
---|---|---|---|---|
Use of an arterial line, n (%) | 25 (25) | 17 (17) | 8 (− 4 to 20) | 1.5 (0.9 to 2.6) |
Use of a central venous catheter, femoral vein catheter, or peripherally inserted central catheter, n (%) | 31 (31) | 21 (21) | 10 (− 3 to 23) | 1.5 (0.9 to 2.5) |
Anticoagulation or anti-platelet agents, n (%) | 38 (38) | 35 (35) | 3 (− 11 to 17) | 1.1 (0.8 to 1.6) |
Renal replacement therapy, n (%) | 17 (17) | 18 (18) | − 1 (− 12 to 10) | 1 (0.5 to 1.8) |
Total number of blood tests per patient, median (IQR)a | ||||
Hematology | 2.0 (1–3) | 2.0 (1–4) | 0 | 0.8 (0.6 to 1.1) |
Chemistryb | 5.0 (3–8) | 4.0 (2–8) | NA | NA |
Immunology | 0 (0–1) | 1.0 (0–1) | − 1 | 0.9 (0.7 to 1.4) |
Coagulation | 0 (0–1) | 0 (0–1) | 0 | 0.9 (0.4 to 1.8) |
Lactate | 1 (0–2) | 0 (0–2) | 1 | 1.1 (0.6 to 1.8) |
Blood gasses | 1 (0–3) | 1 (0–4) | 0 | 0.8 (0.5 to 1.3) |
Blood culture bottles | 0 (0–0) | 0 (0–0) | 0 | 1 (0.5 to 1.9) |
Phlebotomy volumec | ||||
Per participant per day, mL, median (IQR) | 8.6 (4–18) | 21.6 (15–31) | − 13 | 0.5 (0.4 to 0.6) |
Total per participant, mL, median (IQR) | 21 (7–38) | 50 (27–100) | − 29 | 0.4 (0.3 to 0.6) |
Total per participant as a percentage of their estimated blood volume, %, median (IQR) | 0.4 (0.2–0.7) | 1.1 (0.6–2.1) | − 0.7 | 0.3 (0.2 to 0.5) |